Sage lays off 40%, shakes up C-suite to squeeze a profit out of partially rejected zuranolone -- Wegovy costs $1.1m to prevent one heart attack, stroke, or cardiovascular death -- AI is a game changer for toughest areas of drug discovery -- See more on our front page news http://bit.ly/w28kSd #sagetherapeutics #zuranolone #depression #layoffs #novonordisk #wegovy #heartattack #ai #artificialintelligence #drugdiscovery #pharma #pharmanews #biotech #biopharma #biotechnology #cafepharma